Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2117]

New discovery means IV medication could be taken orally for range of cancer, Alzheimer’s treatments

New discovery means IV medication could be taken orally for range of cancer, Alzheimer’s treatments

Discovery of FOXR2 activation in various brain tumours refines diagnosis to improve care

Discovery of FOXR2 activation in various brain tumours refines diagnosis to improve care

Overcoming cancer drug resistance

Overcoming cancer drug resistance

Vanessa Moss prize celebrates cancer health disparities research

Vanessa Moss prize celebrates cancer health disparities research

Paediatric high-grade gliomas: Research reveals effective targeting with avapritinib

Paediatric high-grade gliomas: Research reveals effective targeting with avapritinib

Research discovers a way to slow or block recurrence of glioblastoma

Research discovers a way to slow or block recurrence of glioblastoma

Revolutionising protein modification: a new frontier in cancer research

Revolutionising protein modification: a new frontier in cancer research

Efficacy endpoint changes in glioblastoma phase II clinical trials and the factors contributing to these changes

Efficacy endpoint changes in glioblastoma phase II clinical trials and the factors contributing to these changes

New drug therapy combination shows promise for advanced melanoma patients

New drug therapy combination shows promise for advanced melanoma patients

Fudan team develops a novel CRG-based classification model for IDH1-mutant gliomas, advancing precision therapy optimisation

Fudan team develops a novel CRG-based classification model for IDH1-mutant gliomas, advancing precision therapy...

More from ecancer